152 related articles for article (PubMed ID: 16641040)
1. Accelerated atherosclerosis, arterial thromboembolism, and preventive strategies in systemic lupus erythematosus.
Mok CC
Scand J Rheumatol; 2006; 35(2):85-95. PubMed ID: 16641040
[TBL] [Abstract][Full Text] [Related]
2. 'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus.
Bruce IN
Rheumatology (Oxford); 2005 Dec; 44(12):1492-502. PubMed ID: 16234277
[TBL] [Abstract][Full Text] [Related]
3. Premature coronary heart disease in SLE: can we prevent progression?
Iaccarino L; Bettio S; Zen M; Nalotto L; Gatto M; Ramonda R; Punzi L; Doria A
Lupus; 2013 Oct; 22(12):1232-42. PubMed ID: 24097995
[TBL] [Abstract][Full Text] [Related]
4. Systemic lupus erythematosus, atherosclerosis, and autoantibodies.
Zampieri S; Iaccarino L; Ghirardello A; Tarricone E; Arienti S; Sarzi-Puttini P; Gambari P; Doria A
Ann N Y Acad Sci; 2005 Jun; 1051():351-61. PubMed ID: 16126977
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular risk assessment and treatment in systemic lupus erythematosus.
Elliott JR; Manzi S
Best Pract Res Clin Rheumatol; 2009 Aug; 23(4):481-94. PubMed ID: 19591779
[TBL] [Abstract][Full Text] [Related]
6. Atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus.
Haque S; Mirjafari H; Bruce IN
Curr Opin Lipidol; 2008 Aug; 19(4):338-43. PubMed ID: 18607179
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
Zhang CY; Lu LJ; Li FH; Li HL; Gu YY; Chen SL; Bao CD
J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290
[TBL] [Abstract][Full Text] [Related]
8. Damage, accelerated atherosclerosis, and mortality in patients with systemic lupus erythematosus: lessons from LUMINA, a multiethnic US cohort.
Durán S; González LA; Alarcón GS
J Clin Rheumatol; 2007 Dec; 13(6):350-3. PubMed ID: 18176147
[No Abstract] [Full Text] [Related]
9. Controversies and advances in the management of systemic lupus erythematosus in children and adolescents.
Tucker LB
Best Pract Res Clin Rheumatol; 2002 Jul; 16(3):471-80. PubMed ID: 12387811
[TBL] [Abstract][Full Text] [Related]
10. [Lupus nephritis as a factor of atherosclerosis risk in patients with systemic lupus erythematosus].
Serikova SIu; Kozlovskaia NL; Shilov EM
Ter Arkh; 2008; 80(6):52-8. PubMed ID: 18655477
[TBL] [Abstract][Full Text] [Related]
11. Dual effects of statins therapy in systemic lupus erythematosus and SLE-related atherosclerosis: the potential role for regulatory T cells.
Tu H; Li Q; Xiang S; Jiang H; Mao Y; Shou Z; Chen J
Atherosclerosis; 2012 May; 222(1):29-33. PubMed ID: 22417842
[TBL] [Abstract][Full Text] [Related]
12. Should all patients with systemic lupus erythematosus receive cardioprotection with statins?
Toloza S; Urowitz MB; Gladman DD
Nat Clin Pract Rheumatol; 2007 Oct; 3(10):536-7. PubMed ID: 17700557
[No Abstract] [Full Text] [Related]
13. Premature atherosclerosis-related central nervous system involvement in two cases of systemic lupus erythematosus.
Zhang X; Tian X; Zhang F
J Clin Rheumatol; 2007 Aug; 13(4):211-2. PubMed ID: 17762456
[TBL] [Abstract][Full Text] [Related]
14. Accelerated atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus.
Farzaneh-Far A; Roman MJ
Int J Clin Pract; 2005 Jul; 59(7):823-4. PubMed ID: 15963210
[TBL] [Abstract][Full Text] [Related]
15. Preventive strategies in systemic lupus erythematosus.
Doria A; Arienti S; Rampudda M; Canova M; Tonon M; Sarzi-Puttini P
Autoimmun Rev; 2008 Jan; 7(3):192-7. PubMed ID: 18190877
[TBL] [Abstract][Full Text] [Related]
16. Accelerated atherosclerosis in patients with systemic autoimmune diseases.
de Leeuw K; Kallenberg C; Bijl M
Ann N Y Acad Sci; 2005 Jun; 1051():362-71. PubMed ID: 16126978
[TBL] [Abstract][Full Text] [Related]
17. Premature atherosclerotic cardiovascular disease in systemic lupus erythematosus: understanding management strategies.
Turano L
J Cardiovasc Nurs; 2013; 28(1):48-53. PubMed ID: 22210142
[TBL] [Abstract][Full Text] [Related]
18. Accumulation of advanced glycation endproducts in patients with systemic lupus erythematosus.
de Leeuw K; Graaff R; de Vries R; Dullaart RP; Smit AJ; Kallenberg CG; Bijl M
Rheumatology (Oxford); 2007 Oct; 46(10):1551-6. PubMed ID: 17848401
[TBL] [Abstract][Full Text] [Related]
19. Factors determining participation in prevention trials among systemic lupus erythematosus patients: a qualitative study.
Costenbader KH; Brome D; Blanch D; Gall V; Karlson E; Liang MH
Arthritis Rheum; 2007 Feb; 57(1):49-55. PubMed ID: 17266094
[TBL] [Abstract][Full Text] [Related]
20. Traditional and nontraditional risk factors for atherosclerosis in patients with systemic lupus erythematosus.
Pompilian V; Badea C; Dragomanu I; Bălăşescu E; Tănăsescu C
Rom J Intern Med; 2008; 46(3):195-8. PubMed ID: 19366077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
